相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impaired Activated/Memory Regulatory T Cell Clonal Expansion Instigates Diabetes in NOD Mice
Vanessa Mhanna et al.
DIABETES (2021)
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
Paul N. Harden et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Type 1 diabetes-early life origins and changing epidemiology
Jill M. Norris et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Mucosal-associated invariant T cell alterations during the development of human type 1 diabetes
Ahmad M. Gazali et al.
DIABETOLOGIA (2020)
Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function
Yuchi Honaker et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
Andy Roemhild et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy
M. Dur et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes
Michel Tenspolde et al.
JOURNAL OF AUTOIMMUNITY (2019)
Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes
Chiara Sorini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells
Nicholas A. J. Dawson et al.
JCI INSIGHT (2019)
Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells
Suchitra Prasad et al.
JOURNAL OF AUTOIMMUNITY (2018)
Engineering the immune system with particles, step-by-step
B. G. De Geest
MOLECULAR IMMUNOLOGY (2018)
Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance
James M. Mathew et al.
SCIENTIFIC REPORTS (2018)
Treg cells-the next frontier of cell therapy Will regulatory T cells be a frontline therapy for autoimmunity and other diseases?
Jeffrey A. Bluestone et al.
SCIENCE (2018)
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells
Tatiana Takiishi et al.
DIABETES (2017)
Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice
Connor J. Dwyer et al.
SCIENCE SIGNALING (2017)
Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice
Connor J. Dwyer et al.
SCIENCE SIGNALING (2017)
Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes
Ophelie Rouxel et al.
NATURE IMMUNOLOGY (2017)
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants
S. Chandran et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Advances in the Use of Regulatory T-Cells for the Prevention and Therapy of Graft-vs.-Host Disease
Reshma Ramlal et al.
BIOMEDICINES (2017)
Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection
D. A. Boardman et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor
F. Noyan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Immune Tolerance for Autoimmune Disease and Cell Transplantation
Xunrong Luo et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 18 (2016)
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
Katherine G. MacDonald et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Expanding antigen-specific regulatory networks to treat autoimmunity
Xavier Clemente-Casares et al.
NATURE (2016)
Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2
Ada Yeste et al.
SCIENCE SIGNALING (2016)
Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2
Ada Yeste et al.
SCIENCE SIGNALING (2016)
Biomaterial Strategies for Immunomodulation
Nathan A. Hotaling et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 17 (2015)
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
Michelle Rosenzwajg et al.
JOURNAL OF AUTOIMMUNITY (2015)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Therapy of type 1 diabetes with CD4+CD25high CD127-regulatory T cells prolongs survival of pancreatic islets - Results of one year follow-up
Natalia Marek-Trzonkowska et al.
CLINICAL IMMUNOLOGY (2014)
Molecular Mechanisms in Autoimmune Type 1 Diabetes: a Critical Review
Zhiguo Xie et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2014)
Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis Reverses Diabetes in Recent-Onset NOD Mice
Sofie Robert et al.
DIABETES (2014)
Clinical Grade Manufacturing of Human Alloantigen-Reactive Regulatory T Cells for Use in Transplantation
A. L. Putnam et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
IL-2 therapy in type 1 diabetes: Trials and tribulations
S. Alice Long et al.
CLINICAL IMMUNOLOGY (2013)
Trials in type 1 diabetes: Antigen-specific therapies
Ken T. Coppieters et al.
CLINICAL IMMUNOLOGY (2013)
Administration of CD4+CD25highCD127- Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children
Natalia Marek-Trzonkowska et al.
DIABETES CARE (2012)
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Mauro Di Ianni et al.
BLOOD (2011)
Insulin as a key autoantigen in the development of type 1 diabetes
Maki Nakayama
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Tom L. Van Belle et al.
PHYSIOLOGICAL REVIEWS (2011)
The Long and Winding Road to Understanding and Conquering Type 1 Diabetes
Pere Santamaria
IMMUNITY (2010)
Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?
Xunrong Luo et al.
IMMUNITY (2010)
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
Yenkel Grinberg-Bleyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis
Francisco J. Quintana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study
S. L. Thrower et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127-T regulatory cells
Piotr Trzonkowski et al.
CLINICAL IMMUNOLOGY (2009)
Commonality in the genetic control of Type 1 diabetes in humans and NOD mice: variants of genes in the IL-2 pathway are associated with autoimmune diabetes in both species
Dan B. Rainbow et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells
Ehud Hauben et al.
BLOOD (2008)
Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction
Qizhi Tang et al.
IMMUNITY (2008)
Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes
Christopher E. Lowe et al.
NATURE GENETICS (2007)
Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
Kristin V. Tarbell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice
EL Masteller et al.
JOURNAL OF IMMUNOLOGY (2005)
Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes
S Lindley et al.
DIABETES (2005)
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes
QZ Tang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes
KV Tarbell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
H Ueda et al.
NATURE (2003)
分享论文
